An adherent cell isotopic staphylococcal protein A test (ISPAT) was used to estimate the abundance of mouse mammary tumor virus (MMTV) gp52 cell surface antigen (CSA) on mammary tumor cells. Protein A assays were first utilized, not strictly as a means of antigen detection, but as a means to determine the kinetics of dexamethasone-mediated changes in gp52 cell surface expression. Results indicated increases in gρ52 CSA within 4 h of dexamethasone treatment and maximal levels of antigen expression within 12–24 h after treatment. Comparison of gp52 determinants on dexamethasone-stimulated mammary tumor cells demonstrated a greater abundance on C3H Mm5mt/cl than on GR-MMTV cultures. Parallel antigen assays with gp52 and Rauscher murine leukemia virus (R-MuLV) antisera demonstrated that GR-MMTV cells expressed fewer C-type determinants and thus a more preferential expression of gp52 determinants than other cell lines tested. The gp52/R-MuLV binding ratio was only 2.4:1 for C3H cultures in contrast to 5.7:1 for GR cultures. In addition, a comparison of gp52 expression on viral producer and nonproducer cells provided a quantitative estimate of the extent of expression which occurred in a retrovirus nonproducer culture. Results of ISPAT demonstrated that 75% of the gp52 detected on producer cells was present on nonproducer cultures. Comparison of the expression of gp52 CSA and the release of gp52 into culture fluids during hormone treatments demonstrated that both assays (ISPAT and gp52 radioimmuno-assay) detect and quantitate coordinate changes in the expression and release of MMTV gp52. In antibody excess, protein A assays provided quantitative estimates of CSA abundance not offered by alternative methods of CSA detection.

Keywords:
Mammary tumor virus, Glycoprotein expression, Mammary tumor cell, Protein A assay
This content is only available via PDF.
© 1981 S. Karger AG, Basel
1981
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.